A detailed history of Sg Americas Securities, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 15,514 shares of ANIX stock, worth $43,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,514
Holding current value
$43,284
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025

BUY
$2.13 - $3.29 $33,044 - $51,041
15,514 New
15,514 $44,000
Q2 2019

Jul 29, 2019

SELL
$3.47 - $4.75 $352,607 - $482,676
-101,616 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$3.85 - $5.53 $391,221 - $561,936
101,616 New
101,616 $459,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $85.5M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.